Anti-cancer activities of pH- or heat-modified pectin

Lionel Leclere1, Pierre Van Cutsem, Carine Michiels

  • 1Unité de Recherche en Biologie Cellulaire, Namur Research Institute for Life Sciences, University of Namur Namur, Belgium.

Frontiers in Pharmacology
|October 12, 2013
PubMed

Insights

Pectin and modified pectin show anticancer and chemopreventive effects, offering a natural alternative to combat cancer drug resistance and potentially enhance conventional treatments.

Area of Science:

  • Natural product chemistry
  • Oncology
  • Pharmacology

Background:

  • Cancer remains a significant global health challenge.
  • Chemotherapy resistance limits treatment efficacy and patient outcomes.
  • Natural products are explored as alternatives to overcome drug resistance.

Purpose of the Study:

  • To review the chemopreventive and antitumoral activities of pectin and modified pectin.
  • To elucidate the mechanisms underlying pectin's anticancer effects.
  • To assess the potential of pectin derivatives in cancer therapy.

Main Methods:

  • Literature review of studies on pectin and modified pectin in cancer.
  • Analysis of research on the biological activities and mechanisms of pectin.
  • Evaluation of pectin's role in cancer chemoprevention and treatment.

Main Results:

  • Pectin and modified pectin exhibit significant chemopreventive and antitumoral properties.
  • These natural compounds show potential against aggressive and recurrent cancers.
  • Mechanisms involve various pathways contributing to anticancer effects.

Conclusions:

  • Pectin-derived products demonstrate promising anticancer activities.
  • They offer a potential strategy to overcome chemotherapy resistance.
  • Pectin holds promise for synergistic use with conventional anticancer drugs.